The marketing analysis of paracetamol and ibuprofen for the treatment of acute respiratory infections in Ukraine

Abstract

Aim. To conduct the marketing analysis of medicines registered in Ukraine with the international nonproprietary name (INN) – ibuprofen and paracetamol for the treatment of acute respiratory infections (ARI).
 Materials and methods. The data of the State Register of Medicines of Ukraine, the data of the Register of wholesale and selling prices for medicines in Ukraine as of March 2021 were used. Bibliosemantic, marketing, analytical, graphic, frequency and descriptive analyses were applied.
 Results. The marketing analysis of ibuprofen and paracetamol revealed their different drug forms, namely children’s forms were presented in the form of suspensions, syrups, suppositories, while adults forms – in the form of tablets, capsules, sachets, injectable dosage forms. It was found that ibuprofen was represented at the pharmaceutical market of Ukraine by 10 trade names (TN) in the form of tablets, 5 TN in the form of capsules. 7 TN of Paracetamol were presented in the form of a solution for injection at the pharmaceutical market of Ukraine, 10 TN were in the form of tablets, and 2 TN were in the form of suppositories. The cost of ibuprofen and paracetamol was studied: the cost of 1 package of children’s medicines ranged from 17.2 to 102.31 UAH, ibuprofen – from 16.2 to 150 UAH, paracetamol – from 15.09 to 980 UAH. The most expensive paracetamol was represented by the trade name Parafusiv (paracetamol, 10 mg/ml for inf., 100 ml vial, 10 mg/ml, No.10 (Portugal)).
 Conclusions. The marketing research of ibuprofen and paracetamol has shown their diversity at the pharmaceutical market of Ukraine. These drugs are represented by a wide range of trade names, drug forms, manufacturers and a wide range of prices. The country-manufacturer of all drugs presented is Ukraine (73 %).